Public Employees Retirement System of Ohio Cuts Position in National Health Investors, Inc. $NHI

Public Employees Retirement System of Ohio decreased its stake in National Health Investors, Inc. (NYSE:NHI) by 17.3% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 54,036 shares of the real estate investment trust’s stock after selling 11,307 shares during the period. Public Employees Retirement System of Ohio owned approximately 0.11% of National Health Investors worth $4,369,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. International Assets Investment Management LLC purchased a new position in National Health Investors in the fourth quarter valued at about $27,000. EverSource Wealth Advisors LLC boosted its stake in shares of National Health Investors by 244.1% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust’s stock worth $28,000 after acquiring an additional 288 shares in the last quarter. Garton & Associates Financial Advisors LLC purchased a new stake in shares of National Health Investors during the 4th quarter worth approximately $33,000. GAMMA Investing LLC grew its holdings in shares of National Health Investors by 41.8% in the 4th quarter. GAMMA Investing LLC now owns 461 shares of the real estate investment trust’s stock worth $35,000 after acquiring an additional 136 shares during the period. Finally, Key Capital Management INC purchased a new position in National Health Investors in the 4th quarter valued at approximately $47,000. Hedge funds and other institutional investors own 62.51% of the company’s stock.

Insiders Place Their Bets

In other National Health Investors news, CEO D. Eric Mendelsohn acquired 1,500 shares of the firm’s stock in a transaction dated Friday, June 5th. The shares were acquired at an average price of $68.84 per share, for a total transaction of $103,260.00. Following the completion of the acquisition, the chief executive officer directly owned 133,316 shares of the company’s stock, valued at $9,177,473.44. This trade represents a 1.14% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Robert A. Mccabe, Jr. acquired 890 shares of the stock in a transaction dated Monday, June 15th. The stock was acquired at an average cost of $71.65 per share, with a total value of $63,768.50. Following the transaction, the director owned 44,159 shares of the company’s stock, valued at approximately $3,163,992.35. This trade represents a 2.06% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Corporate insiders own 2.70% of the company’s stock.

National Health Investors Stock Performance

Shares of NHI opened at $78.18 on Thursday. The company has a debt-to-equity ratio of 0.83, a quick ratio of 8.20 and a current ratio of 8.20. The company has a market capitalization of $3.79 billion, a price-to-earnings ratio of 25.22, a PEG ratio of 3.53 and a beta of 0.51. The company’s 50 day simple moving average is $75.14 and its 200 day simple moving average is $79.77. National Health Investors, Inc. has a 1 year low of $67.94 and a 1 year high of $91.38.

National Health Investors Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, August 7th. Shareholders of record on Tuesday, June 30th will be issued a $0.92 dividend. The ex-dividend date is Tuesday, June 30th. This represents a $3.68 annualized dividend and a yield of 4.7%. National Health Investors’s payout ratio is 118.71%.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on NHI shares. Zacks Research cut National Health Investors from a “hold” rating to a “strong sell” rating in a report on Thursday, June 25th. Wells Fargo & Company dropped their price target on National Health Investors from $84.00 to $79.00 and set an “equal weight” rating for the company in a research report on Monday, June 1st. Deutsche Bank Aktiengesellschaft cut their price target on National Health Investors from $85.00 to $80.00 and set a “hold” rating for the company in a research note on Thursday, June 25th. BMO Capital Markets decreased their price objective on shares of National Health Investors from $90.00 to $80.00 and set an “outperform” rating on the stock in a research report on Monday, June 15th. Finally, Cantor Fitzgerald reissued an “overweight” rating and issued a $94.00 price objective on shares of National Health Investors in a research note on Wednesday, April 22nd. Five analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $83.86.

National Health Investors Profile

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.